| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |